Essent Group ESNT

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.46 (+0.79%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

Key Insights

Essent Group (ESNT) Core Market Data and Business Metrics
  • Latest Closing Price

    $58.7
  • Price-Earnings Ratio

    8.51
  • Total Outstanding Shares

    103.84 Million Shares
  • Dividend

    $0.31 Per Share Quarterly
  • SIC Description

    Surety Insurance
  • Primary Exchange

    New York Stock Exchange
  • Headquarters

    Clarendon House, Hamilton, D0, HM 11

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily VolumeDays to CoverSettlement DateShort Interest
802,703 Shares2.253/14/20251,803,362 Shares
959,238 Shares1.422/28/20251,365,274 Shares
744,220 Shares1.992/14/20251,481,782 Shares
714,994 Shares2.541/31/20251,813,800 Shares
898,569 Shares2.051/15/20251,838,772 Shares
740,098 Shares2.0312/31/20241,498,858 Shares

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow$12.53 Million
Net Cash Flow From Operating Activities, Continuing$850.28 Million
Net Cash Flow From Financing Activities$-109.50 Million
Net Cash Flow From Investing Activities$-728.25 Million
Net Cash Flow, Continuing$12.53 Million
Net Cash Flow From Financing Activities, Continuing$-109.50 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Preferred Stock Dividends And Other Adjustments$0
Income/Loss From Continuing Operations After Tax$736.87 Million
Diluted Average Shares$320.00 Million
Net Income/Loss Available To Common Stockholders, Basic$736.87 Million
Income/Loss From Equity Method Investments$65,000

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Other Comprehensive Income/Loss Attributable To Parent$246.10 Million
Other Comprehensive Income/Loss$982.97 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$982.97 Million
Comprehensive Income/Loss Attributable To Parent$982.97 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity$5.64 Billion
Fixed Assets$41.22 Million
Liabilities And Equity$7.13 Billion
Equity Attributable To Noncontrolling Interest$0
Current Liabilities$1.49 Billion
Liabilities$1.49 Billion

Historical Dividends

Current dividend: $0.31 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Feb 14, 2025Mar 24, 2025Mar 14, 2025$0.31Quarterly
Nov 1, 2024Dec 11, 2024Dec 2, 2024$0.28Quarterly
Aug 2, 2024Sep 10, 2024Aug 30, 2024$0.28Quarterly
May 2, 2024Jun 10, 2024May 31, 2024$0.28Quarterly
Feb 9, 2024Mar 22, 2024Mar 13, 2024$0.28Quarterly
Nov 2, 2023Dec 11, 2023Dec 1, 2023$0.25Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about ESNT from trusted financial sources

    Related Companies

    Publicly traded companies similar to Essent Group (ESNT)